| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2143961 | Lung Cancer | 2007 | 7 Pages |
Abstract
The sequential administration of docetaxel and gefitinib was well tolerated and moderately active against advanced pre-treated NSCLC.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
A.G. Pallis, Ch. Christofillakis, E. Tselepatiotis, S. Agelaki, L. Vamvakas, J. Souglakos, N. Vardakis, A. Kalykaki, A. Kotsakis, A. Argiraki, D. Mavroudis, V. Georgoulias,